VRTX
VERTEX PHARM
Health Care·Biotechnology·UNITED STATES
$540.26
MCap $136.9B
as of 2026-08-20
Total
B3w
Fund
C9w
Quant
A2w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-08-20
MIDOS SI
-0.21
Sentiment 71.6%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$540.26
Adaptive Mean
$543.42
-3.16 vs mean
Adaptive σ
7.63
MIDOS BB
$528.16 – $558.68
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-21
Composite Z
+0.13
ROE
23.5%
Z +0.65
Rev Gr
12.5%
Z -0.23
EPS Gr
8.0%
Z -0.05
OPM Gr
-0.9%
Z +0.11
FCF Yld
1.9%
Z +0.26
EPS Surp
-0.0%
Z -0.02
EPS 3mo Δ
2.3%
Z +0.17
Fwd P/E
25.14
Z —
PEGY
3.14
Expensive
Momentum (Risk-Adjusted Alpha)
as of 2026-08-21
Q3M
17.41
Q6M
4.07
Q12M
5.36
MA 30/100
1.069
Bullish (MA30 > MA100)
α (Jensen)
0.9098
β (12M)
0.47
σ (12M)
0.286
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
72%
Q Percentile
79%
Divergence
-7.5
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
-2.2
RS Pctl
58%
RS Decile
D6
Persistence
3w
at grade B
Options / OI Analysis
No options or Williams data available for this ticker.